Stockscreener 앱 받기
9.3895
1.32%
-0.1205
Zevra Therapeutics Inc 주식(ZVRA)의 최신 뉴스
Chart overlay techniques for tracking Zevra Therapeutics Inc.2025 Buyback Activity & Precise Buy Zone Tips - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock draw ESG focused fundsTake Profit & Fast Exit/Entry Strategy Plans - newser.com
How institutional ownership impacts Zevra Therapeutics Inc. stockJuly 2025 Movers & Verified Chart Pattern Trade Signals - newser.com
How to use a screener to detect Zevra Therapeutics Inc. breakoutsInsider Buying & Free Technical Pattern Based Buy Signals - newser.com
Visual trend scoring systems applied to Zevra Therapeutics Inc.July 2025 Earnings & Consistent Growth Equity Picks - newser.com
What drives Zevra Therapeutics Inc stock priceFibonacci Extensions & Rapid Capital Trading Tips - earlytimes.in
How Zevra Therapeutics Inc. (1GDA) stock trades in high volatilityJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock benefit from Fed rate cutsJuly 2025 Intraday Action & Community Trade Idea Sharing - newser.com
Can trapped investors hope for a rebound in Zevra Therapeutics Inc.Earnings Miss & Fast Gain Stock Trading Tips - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock test record highs in 20252025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Will Zevra Therapeutics Inc. rebound enough to break evenQuarterly Market Summary & Safe Capital Growth Trade Ideas - newser.com
Is Zevra Therapeutics Inc. trending in predictive chart modelsWeekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Can Zevra Therapeutics Inc. (1GDA) stock sustain breakout momentumPortfolio Profit Report & Expert Verified Movement Alerts - newser.com
What drives Zevra Therapeutics Inc 1GDA stock priceEarnings Revision Updates & Fast Profit Trading Strategies - earlytimes.in
Can Zevra Therapeutics (ZVRA) Turn Clinical Momentum Into Sustainable Competitive Advantage? - Yahoo Finance
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Zevra Therapeutics (NASDAQ:ZVRA) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Zevra Therapeutics Inc Stock Analysis and ForecastMarket Depth Overview & Top Analyst Picks Available for Free - Early Times
Zevra Therapeutics rises amid takeover speculation - MSN
Zevra Therapeutics (ZVRA) Sees Surge on Takeover Speculation - GuruFocus
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap UpHere's Why - MarketBeat
Zevra Therapeutics Sees Unusually High Options Volume (NASDAQ:ZVRA) - MarketBeat
Zevra Therapeutics rises amid takeover speculation (ZVRA:NASDAQ) - Seeking Alpha
Zevra Therapeutics (ZVRA) Soars 10.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Goldman Sachs Group Inc. Has $1.46 Million Stake in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Tamara A. Favorito Acquires 3,175 Shares of Zevra Therapeutics (NASDAQ:ZVRA) Stock - MarketBeat
Aug Drivers: Is Zevra Therapeutics Inc in a long term uptrendJuly 2025 Institutional & Stepwise Trade Signal Guides - خودرو بانک
Aug Wrap: Is Zevra Therapeutics Inc. trading at a discount2025 Earnings Impact & Low Drawdown Investment Ideas - خودرو بانک
Bear Alert: Can Zevra Therapeutics Inc stock double in the next year2025 Earnings Surprises & Stock Timing and Entry Methods - خودرو بانک
Aug Shorts: What is Zevra Therapeutics Incs market positionEarnings Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
Zevra Therapeutics (NASDAQ:ZVRA) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Zevra Therapeutics Announces Upcoming Oral Presentation at - GlobeNewswire
Support Test: Will Zevra Therapeutics Inc benefit from geopolitical trends2025 Technical Overview & Verified Chart Pattern Trade Signals - خودرو بانک
Short Squeeze: Can Zevra Therapeutics Inc benefit from deglobalization2025 Momentum Check & Verified Swing Trading Watchlists - خودرو بانک
Alvin Shih Adds To Zevra Therapeutics Holding - 富途牛牛
Zevra Therapeutics Announces Presentations on MIPLYFFA® and OLPRUVA® at Upcoming International Conferences - Quiver Quantitative
Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sod - GlobeNewswire
First Drug to Stop NPC Disease Progression: Zevra's MIPLYFFA Shows Breakthrough Results in 270 Patients - Stock Titan
Zevra Therapeutics (ZVRA) Announces Positive New Data Supporting Foundational Role of MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C - Yahoo Finance
RSI Check: Is Zevra Therapeutics Inc. in a long term uptrendQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک
Insider Buying: Tamara Favorito Acquires Shares of Zevra Therapeutics Inc (ZVRA) - GuruFocus
A Fresh Look at Zevra Therapeutics (ZVRA) Valuation Following New MIPLYFFA Data Release - Yahoo Finance
Alvin Shih At Zevra Therapeutics Tops Up Holding By US$158k - simplywall.st
Published on: 2025-09-16 13:04:37 - khodrobank.com
Woodline Partners LP Raises Holdings in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics gains amid takeover speculation - MSN
Insider Buying: Alvin Shih Acquires 20,000 Shares of Zevra Therapeutics Inc (ZVRA) - GuruFocus
2.76%
자본화:
|
볼륨(24시간):